Incyte Investing Cash Flow decreased by 135.7% to -$88.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8140.4%, from $1.10M to -$88.20M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -20.9% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$49.15M | -$32.75M | -$66.05M | -$16.75M | -$12.48M | -$28.40M | -$20.91M | -$28.56M | -$7.43M | -$17.19M | -$154.50M | -$73.11M | $213.82M | $38.27M | $1.10M | -$18.87M | -$47.42M | -$37.42M | -$88.20M |
| QoQ Change | — | +33.4% | -101.6% | +74.6% | +25.5% | -127.6% | +26.4% | -36.6% | +74.0% | -131.4% | -798.8% | +52.7% | +392.5% | -82.1% | -97.1% | <-999% | -151.3% | +21.1% | -135.7% |
| YoY Change | — | — | — | — | +74.6% | +13.3% | +68.3% | -70.5% | +40.5% | +39.5% | -638.8% | -156.0% | >999% | +322.7% | +101.5% | -108.8% | -223.9% | — | <-999% |